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Summary points 
 
Clinical trials need a control, but if handled correctly this need not run in parallel with the 
intervention. 
 
There are various designs for cluster randomised trials involving more than one cross-section. 
 
Multiple cross-sections mean fewer clusters are required, but could result in a heavy burden of 
individual recruitment. 
 
Nevertheless, it is possible to add a cross-section to a design with a single follow-up and reduce both 
the number of clusters and the number of individual participants needed. 
In 1948 the UK Medical Research Council’s streptomycin trial established the principles of the 
modern clinical trial,1 and for longer still the idea of a comparison group recruited concurrently to 
the intervention group has been recognised as essential to obtaining sound evidence for clinical 
effectiveness.2 But must a trial proceed by running an intervention and comparator in parallel? In 
this article we focus on trials where participants are randomised in clusters such as general practices 
or schools. This is common when evaluating interventions applied at cluster level.3 We look at trials 
where the comparator is routine care, which effectively ask how individuals’ outcomes would 
compare before and after introducing the intervention in a cluster. We discuss efficient alternatives 
to parallel group trial designs in this case – made possible by delaying introduction of the 
intervention in some clusters after randomisation, with these clusters continuing in the meantime to 
receive routine care. 
 
Exemplar study 
 
Murphy and colleagues evaluated a free school breakfast programme in Wales using a cluster 
randomised trial with schools as clusters.4 At each of 111 schools, a baseline sample of around 50 
children aged 9-11 years completed assessments of behavior, cognitive performance, and diet. Half 
the schools were randomised to receive the intervention. One year later, a new sample of 9-11-year-
old children was taken at each school. Because a different sample of children is taken on each 
occasion we would describe the design as involving repeated cross sections.5 We refer to the 
particular design used by Murphy and colleagues as a parallel group design with a baseline 
assessment (fig). It is analogous to an analysis of covariance design for an individually randomised 
trial.6,7 
 
In this article we consider sample size requirements for cluster randomised trials with a variety of 
designs involving repeated cross-sections. In particular we focus on designs where the introduction 
of the intervention is delayed for longer in some arms than others. In this case, we make the 
fundamental assumption that the effect of the intervention – that is, the difference in outcome 
between individuals in clusters who receive the intervention and individuals in clusters continuing to 
receive routine care – is the same regardless of that delay. Clusters must be able to provide a fresh 
sample of eligible individuals at each new cross section. We assume a multilevel model where the 
levels are clusters, cross sections, and individuals. 
 
Crossover vs cross forward designs 
 
An alternative to a parallel group design is a crossover design in which intervention and control arms 
swap over at the end of the first intervention period, with clusters in the control arm then receiving 
the intervention, and clusters in the intervention arm returning to routine care.8 This design would 
not be appropriate if there is a risk of “carry over” within clusters, whereby the clusters have 
supposedly been returned to routine care, but in fact continue to pass on some of the effects of the 
intervention to individuals. Nor would it be appropriate if the intervention is being rolled out as part 
of a policy change, such as in the school breakfast example. In this article we consider designs where 
the transition is in one direction only, from routine care to the new intervention. These are 
sometimes known as one way crossover or unidirectional crossover designs. We suggest a more 
simple description: cross forward designs. 
 
Parallel group designs 
 
The figure illustrates several cross forward designs. At the top is the parallel group design with a 
baseline assessment. Using “B” for “before intervention” and “A” for “after intervention”, we code 
the schedule of assessments in this case as BA in one arm and BB in the other (the control arm 
receives routine care throughout, and is therefore still “before intervention” at follow-up). 
 
The baseline assessment could be discarded, leaving a simple parallel group design. Sample size 
calculations for this design are particularly straightforward.9 We use this design as a reference for 
comparing sample size requirements of other designs with repeated assessments of clusters. In the 
figure, each design shows the relative number of clusters required to achieve the same statistical 
power as a simple parallel group design. We call this the “design effect” due to repeated 
assessment. In each case it depends only on the correlation, r, between two sample means from the 
same cluster in different cross-sections (web appendix). Design effects are derived for normally 
distributed continuous outcome measures but can also be applied to binary outcomes. 10 
 
Stepped wedge designs 
 
If, in a parallel group design with baseline, we give the control clusters the intervention after the first 
follow-up and then follow up both arms a second time, we end up with another kind of cross 
forward design: the stepped wedge – in this case one with two steps (fig). Stepped wedge designs 
can have any number of steps up to and including the total number of clusters, and deliver the 
intervention to all clusters according to a staggered timetable that varies with trial arm, where “arm” 
now simply refers to a randomised group.11,12 Stepped wedge designs are relatively new: a recent 
systematic review found only 25 stepped wedge trials, all but two published since 2000.13 
 
Incomplete cross forward designs 
 
Stepped wedge designs need fewer clusters than parallel group designs with a single follow-up 
simply because they assess the same clusters repeatedly. Alternatives such as parallel group designs 
with multiple baseline or follow-up assessments offer a similar advantage. (Among designs with a 
fixed number of repeated cross-sections, the particular design which minimises the required number 
of clusters depends on the circumstances,12 and further research is needed.) The advantage of 
multiple cross sections is offset, however, by having to recruit a new sample of individuals each time. 
We quantify some of these sample size issues in the next section, but in this section we consider 
how we might reduce both the number of clusters and the number of individual participants 
required while increasing the number of cross sections. This will be worthwhile when trial costs are 
determined mostly by the numbers of individuals and clusters involved rather than by the duration 
of follow-up. 
 
Incomplete cross forward designs leave gaps in the assessment schedule in some trial arms, 
requiring fewer individuals to be recruited.14 The simplest incomplete cross forward design is the 
dog leg, named after the shape made by the assessment schedule (figure).15 This design has no 
baseline assessments (that is, assessments at or before randomisation). Clusters in the first arm are 
assessed after receiving the intervention, but are not assessed again (they may or may not continue 
to receive the intervention, depending on the context). Clusters in the second arm are assessed after 
a period of routine care, and assessed again after receiving the intervention. Clusters in the third 
arm receive routine care throughout, and are assessed once, at the second follow-up. 
 
Elaborations to the dog leg might also be worth investigating (fig). The most obvious place in the 
schedule for an additional assessment is at the first follow-up in the third arm.15 A less obvious 
modification, ensuring that each cluster is assessed twice, is to add a baseline assessment (before 
randomisation) to the first and third arms. Dog-leg designs are a recent methodological 
development, and have not been used for trials so far. 
 
Sample size calculation 
 
The steps involved in calculating required sample size for a cluster randomised trial with repeated 
cross sections are described in table 1. In the school breakfast trial,4 Murphy and colleagues wanted 
80% power at the 5% significance level to detect an effect size (ratio of mean difference to standard 
deviation) of 0.11 for their continuous outcomes. They planned to assess the outcomes of 50 
children in each cross-section at each school, and assumed an intracluster correlation of 0.02.  
 
We start with the sample size for an individually randomised trial with simple parallel group design; 
using standard methods or tables, this is determined to be about 2600.16,17 The relative adjustment 
required for a cluster randomised trial – the design effect due to cluster randomising – is well known 
in this case,9 and evaluates to 1.98 (table 1). 
 
We follow Murphy and colleagues4 and assume a parallel group with baseline design. The next step 
is to calculate the correlation, r, between two sample means from the same cluster at different 
times. This correlation depends on the sample size in each cluster at each cross section, on the 
intracluster correlation,9 and on the reliability of the cluster population mean over time, also known 
as the cluster autocorrelation.7 Murphy and colleagues did not estimate a cluster autocorrelation. In 
the methodological literature this is sometimes assumed to be 1,11 but this assumption will 
underpower repeated cross section trials when individuals sampled from the same cluster at 
different times are more heterogeneous than individuals sampled from the same cluster at the same 
time. As with the intracluster correlation, we could use different values for the cluster 
autocorrelation to see its effect on the required sample size, or calculate a value using similar data 
from completed trials. Here, we assume a cluster autocorrelation of 0.8, which gives r = 0.4040, and 
the design effect due to repeated assessment is then 0.8368 (table 1). 
 
We multiply our initial sample size of 2600 by the respective design effects due to cluster 
randomising and repeated assessment, and divide by the cluster size, giving 88 clusters in all 
(rounded up to a multiple of two since there are two arms). In each arm we take two repeated cross 
sections of 50 children each, so that the total number of participants required is 8800. Table 2 shows 
sample size requirements for other designs. 
 
Comparison of designs 
 
Using the school breakfast programme example,4 the dog leg design requires fewer schools and 
fewer participants than a simple parallel group design or parallel group design with baseline. Murphy 
and colleagues proposed a trial of 11 100 children in 111 schools; a dog leg design requires just 4200 
children in 63 schools. In fact, a dog leg design always requires fewer clusters and fewer participants 
than a simple parallel group design, and likewise a dog leg with baseline always requires fewer 
clusters and fewer participants than a parallel group design with baseline (web appendix). Modifying 
the dog leg by adding another follow-up in the routine care group confers little advantage when r is 
moderate, as our example illustrates. 
 
Risk of bias should be considered carefully with any design. The fundamental assumption of cross 
forward designs – that the effect of the intervention is the same if there is a delay following 
randomisation – may not always hold. For example, if clusters have to perform poorly in some sense 
to be eligible for the trial, they may show a natural improvement over time, and thus offer less room 
for the intervention to show its effect. In incomplete designs, there is a risk of differential attrition of 
clusters in different arms: in a dog leg trial, for example, clusters in the second and third arms are 
followed for longer than clusters in the first arm, and clusters in the third arm may have little contact 
with researchers during the first follow-up period, making them more readily lost to follow-up. 
Because incomplete designs involve different patterns of assessments in different arms, they also 
assume implicitly that the pattern or frequency of previous assessments at cluster level does not 
influence subsequent individual outcomes. Such an influence would be unlikely since different 
individuals are assessed each time, but could arise if, for example, staff at a cluster changed their 
behaviour after observing assessments. In addition, if outcome data from multiple cross sections can 
be obtained at little cost – such as from a pre-existing, anonymised database – then incomplete 
designs lose their appeal. 
 
Conclusions 
 
Clinical trial designs where the same clusters of participants are assessed in more than one cross 
section (allowing intervention clusters to be compared not only with parallel controls but also with 
themselves under an earlier control condition) need fewer clusters than a trial with a single cross 
section, but might also need more participants overall. If investigators want to minimise the overall 
number of participants and are willing to increase the number of cross sections then an incomplete 
design could be worth considering. A dog leg design run over two repeated cross sections, for 
example, needs fewer clusters and fewer participants in total than a trial with a single cross section. 
 
Sample size calculations for cluster randomised trials with repeated cross sections require a cluster 
autocorrelation to be specified in addition to the intracluster correlation, and allows for variation 
over time within a cluster in addition to variation between clusters. Calculations that ignore the 
cluster autocorrelation (like those ignoring the intracluster correlation) risk underpowering a trial. 
Routinely collected time series data, as they become more widely available, should help researchers 
quantify cluster autocorrelations and intracluster correlations, as well as highlighting secular trends 
in outcomes under routine care. 
 
Despite methodological challenges and risk of bias, efficient trial designs such as incomplete cross 
forward designs have an important role. These designs can help researchers meet ethical and 
financial requirements to limit numbers of participants in research,18 as well as create opportunities 
for research in small populations or rare conditions.19 
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 Table 1. Steps in the calculation of sample size for a cluster randomised trial with repeated cross 
sections. 
 
Method School breakfast 
programme 
example 
1. Specify values for:  
m Sample size in each cluster at each cross section 50 
 Intracluster correlation 0.02 
 Cluster autocorrelation 0.8 
 
2. Determine from tables or by calculation:  
n0 No of participants required for an individually 
randomised, simple parallel group design 
2600 
3. Choose a design for the repeated assessments: Simple parallel 
group with baseline 
4. Determine for this design:  
K No of trial arms 2 
s Mean number of cross sections per trial arm, as 
shown in the final column in the figure 
2 
 
5. Calculate the following:  
dc Design effect due to cluster randomising  
 dc = 1 + (m-1) 1.98 
r Correlation between two sample means from 
the same cluster at different times 
 
 r = m/dc 0.4040 
dr Design effect due to repeated assessment, 
calculated using the relevant formula from 
Figure 1, with r calculated above 
 
0.8368 
6. Required sample size is:  
No of clusters =  n0    dc    dr / m 88 
(rounded up to a 
multiple of K) 
No of participants =  m × s    number of clusters 8800 
 
 Table 2. Comparison of sample size requirements for different trial designs in the school breakfast 
programme example.1 
 
Design for repeated assessments2 Schools Participants No of 
follow-up 
times 
Parallel group with baseline 88 8800 1 
Simple parallel group 104 5200 1 
Stepped wedge (2 steps) 80 12 000 2 
Stepped wedge (3 steps) 48 9600 3 
Stepped wedge (4 steps) 36 9000 4 
Dog leg 63 4200 2 
Dog leg with two assessments in routine care arm 63 5250 2 
Dog leg with baseline 57 5700 2 
 
1 To achieve 80% power at the 5% significance level to detect a mean difference equal to 0.11 
standard deviations, assuming cluster size 50, intracluster correlation 0.02, cluster autocorrelation 
0.8. 
2 As shown in the figure.  
  
Figure legends 
 
Figure. Designs for cluster randomised trials comparing outcomes before and after the introduction 
of a new intervention. Figure shows the schedule for repeated assessments and design effect due to 
repeated assessment (assuming equal numbers of clusters in each arm) according to the correlation, 
r, between two sample means from the same cluster at different times. *Design effect assumes the 
effect of the intervention is maintained at the same level once it has been introduced. 
  
Design 
 Schedule for 
repeated 
assessments 
B = before, 
A = after intervention 
Design effect due to 
repeated assessment 
(required number of 
clusters relative to simple 
parallel group design) 
Mean number of 
cross sections 
per cluster 
     
Parallel group with baseline  
 
( 1 – r 2 ) 2 
Simple parallel group  
 
1 1 
Parallel group with multiple 
(u and v) baseline and 
follow-up assessments* 
e.g. 
u=2 
v=2 
 
 u+v 
Stepped wedge (2 steps)*  
 
 
3 
Stepped wedge (w steps)* 
e.g. 
w=3 
 
 
w+1 
Dog leg 
 
 
1⅓ 
Dog leg with two assessments 
in routine care arm 
 
 
1⅔ 
Dog leg with baseline 
 
 
2 
 
 
 
B A 
B B 
A 
B 
B B A A 
B B B B 
( 1 – r ) ( 1 + ( u + v – 1 ) r ) 
v ( 1 + ( u – 1 ) r ) 
B A A 
A B B 
( 1 – r ) ( 1 + 2 r ) 
( 1 + r ) 
B A A A 
A A B B 
B B B A 
3 w ( 1 – r ) ( 1 + w r ) 
( w 2 – 1 ) ( 2 + w r ) 
A 
A B 
B 
3 ( 2 – r ) 
8 
A 
B A 
B B 
18 ( 1 – r 2 ) 
4 ( 7 – 4 r 2 ) 
B A 
B A 
B B 
3 ( 1 – r ) ( 2 + r ) 
8 
A
rm
 
